key: cord-0778213-x0ny87io
authors: XU, Bo; MA, Fu-qiang; HE, Cong; WU, Zi-qi; FAN, Cun-yu; MAO, He-rong; ZHANG, Ji-xian; YANG, Min; HU, Zuo-wei
title: Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China
date: 2022-01-02
journal: J Infect
DOI: 10.1016/j.jinf.2021.12.040
sha: aeaa80e7a3135586dde0d58e13b47be2b045a010
doc_id: 778213
cord_uid: x0ny87io

nan

1. To evaluate the incidence of pulmonary diffusing capacity impairment (PDCI) and the affecting factors in clinical practice of COVID-19 patients 18 months after discharge. 2. Our study suggested that the incidence of PDCI with Chinese COVID-19 survivors 18 months after discharge from our hospital was still high, 3 . The results manifested that females were more susceptible to DLCO impairment than males 4.Pulmonary diffusing capacity was negatively correlated with platelets, that is, the diffusing capacity would be obviously impaired when platelets were at the normal high value, and the pulmonary diffusing capacity would be greatly improved when platelets were at the normal low value convalescent patients with COVID-19 have manifested particularly noticeable pulmonary diffusing capacity impairment (PDCI) 2, 3 . However, the affecting factors for PDCI still remain undefined. We evaluated in this study PDCI of COVID-19 survivors after 18 months of recovery and its affecting factors, aiming to provide reference for treatment of the long COVID patients during the rehabilitation period.

During August to September 2021, we conducted a follow-up study on 221 COVID-19 survivors discharged from Wuhan, Hubei Province, China, who had been hospitalized from January 25 to February 29, 2020.

The inclusion criteria and severity of the disease are based on Chinese clinical guidelines. Clinical data of the survivors, including the demographic characteristics and clinical examinations, were collected by the trained physicians.

Patients underwent the chest HRCT examinations in the supine position and in the breath-holding manner following inspiration. Pulmonary function tests were performed using COSMED Italy under American Thoracic Society and European Respiratory Society guidelines 4 . All pulmonary function test measurements were the percentage of predicted normal values. Inadequate pulmonary diffusing capacity refers to carbon monoxide diffusing capacity of the lungs (DLCO) that is lower than 80% of the predicted values.

This study had been reviewed and approved by the Ethics Committee of Hubei Provincial Hospital of Integrated Traditional Chinese and Western Medicine (2020009). All participants provided their written or verbal consents before the study.

Totally, 221 COVID-19 survivors participated in this study (table1). The patients' median age in this study is 58. There were no significant differences in age, gender and BMI among the survivors before they were infected by COVID-19. This study showed that the PDCI incidence of COVID-19 survivors had reached 57.92% (128/221) and the most commonly-diagnosed complications of the patients were heart failure (3cases [1.36%]), anemia (3 cases [1.36%]) and chronic obstructive pulmonary disease (COPD) (1 case [0.45%]).

The univariate analysis as Table 1 showed that the two groups compared in terms of age, Hb, platelet (PLT), Cr, HbA1c, body mass index (BMI), forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), maximal voluntary ventilation (MVV), CT score and severity of the disease, differences were statistically significant (P＜0.05).

The multivariate logistic regression analysis was performed by taking indexes with statistically significant differences in single factor as the independent variables, and whether survivors' DLCO was damaged as the dependent variable. The results manifested that females were more susceptible to DLCO impairment than males (odd ratio=0.188, 95% CI 0.066-0.532, Wald x2=9.918, df=1, p=0.002). Compared with survivors with impaired DLCO, those with normal DLCO had higher Hb (odd ra-tio=1.025, 95% CI 1.001-1.049, Wald x2=4.192, df=1, p=0.041) and higher MVV (odd ratio=1.020, 95% CI 1.003-1.038, Wald x2=5.429, df=1, p=0.020). Also, survivors with impaired DLCO had higher PLT (odd ratio=0.992, 95% CI 0.985-0.999, Wald x2=0.992, df=1, p=0.031). As the severity of the disease advanced, difficulty for COVID-19 survivors to recover from PDCI was increased (Grade Wald x2= 8.796, df=3, p=0.032). Studies have shown that a large proportion of COVID-19 patients' DLCO has been impaired, likely to associate with the damaged pulmonary interstitium or pulmonary blood vessels 3 . In our study, we reported the lung functions of the mild, moderate, severe and critical cases 18 months after discharge, approximately sixty percent discharged patients still manifested PDCI, although most survivors' vital capacity had been improved significantly or their CT images were normal.

In this study, we discovered the factors affecting COVID-19 patients' PDCI. The multivariate logistic regression analysis showed that gender, Hb, PLT, MVV and the disease severity levels were correlated with the declined pulmonary diffusing capacity. Furthermore, we found that the incidence of PDCI in female patients was significantly higher than that of males, which are in agreement with the previous studies on COVID-19 patients 1 year after discharge 3, 5 .

In the acute phase, PLT activation and aggregation of COVID-19 patients were increased 6, 7 . Histopathological assessment on the autopsy of COVID-19 cases revealed presence of PLT-involved inflammatory microvascular thrombosis in the patients' lungs, kidneys and hearts, confirming that respiratory failure of COVID-19 pa-tients was connected with inflammatory thrombosis [8] [9] [10] . Our study also showed that pulmonary diffusing capacity was negatively correlated with PLT, that is, the diffusing capacity would be obviously impaired when PLTs were at the normal high value, and pulmonary diffusing capacity would be greatly improved when PLTs were at the normal low value.

Moreover, our findings exhibited that after the correction of hemoglobin that affected pulmonary diffusing capacity, the normal high value of hemoglobin was positively correlated with diffusing capacity of the lungs, which could be probably associated with the enhanced capacity of oxygen-carrying of hemoglobin when increased, and with the improved gas exchange in the lungs.

However, FVC and MVV of most COVID-19 survivors with PDCI were normal, which is consistent with other scholars' findings 2 . It should be noted that severity of the disease was closely linked to the survivors' PDCI.

As a cross-sectional study, limitations of this study still exist, and the baseline data are insufficient about the survivors' pulmonary functions prior to the onset of COVID-19.

In summary, our study revealed that 57.92% of COVID-19 patients had PDCI, which was correlated with gender, PLTs, hemoglobin, MVV and severity of COVID-19. The potential factors affecting pulmonary diffusing capacity of COVID-19 patients and the complicated mechanisms behind remain to be further investigated in the future. 

Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review

1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study

Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement

Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinical Medicine

Platelets Promote Thrombo-inflammation in SARS-CoV-2 Pneumonia

Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19

Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy. Circulation

Platelet gene expression and function in patients with COVID-19

Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome

Hu ZW , Yang M and Zhang JX designed the study and generated the analysis plan. Xu B and He C were involved in clinical data collection. Ma FQ and Xu B were involved in statistical analysis. Xu B,Mao HR,Wu ZQ and Fan CYdrafted the paper and conducted the overall analysis. All authors were involved in the final manuscript preparation.

This study was funded by Clinical Study on Prevention and Treatment of COVID-19 by Integrated Traditional Chinese and Western Medicine (2020YFC0841600) under the National Science and Technology Emergency Project.

None.